Literature DB >> 23105634

Serum lipids in hypothyroidism: Our experience.

Archana Prakash1, Ashok Kumar Lal.   

Abstract

In order to determine whether the screening of lipid profile is justified in patients with hypothyroidism we estimated serum lipids in cases having different levels of serum TSH. 60 patients of hypothyroidism in the age group of 20 to 60 yrs were studied for thyroid profile over a period of one year. On the basis of serum TSH level the cases were divided into three groups: In the first group TSH concentration was 8.8±2.99 μlU/ml, 95% confidence interval (Cl) 8.8±1.07, whereas serum total cholesterol and LDL-chol levels were 196±37.22 and 126±29.17 mg/dl respectively. The statistical analysis of these two groups showed a significant correlation between raised TSH levels and serum total cholesterol and LDL-chol (P<0.05 &amp; P<0.01) respectively. We conclude that hypothyrodism is associated with changes in lipid profile.

Entities:  

Keywords:  Cholesterol; Dyslipidemia; Hypothyroidism; Lipid profile; TSH

Year:  2006        PMID: 23105634      PMCID: PMC3454006          DOI: 10.1007/BF02912932

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  Immunoradiometric assay of thyrotropin as a "first-line" thyroid-function test in the routine laboratory.

Authors:  M R Hopton; J S Harrop
Journal:  Clin Chem       Date:  1986-04       Impact factor: 8.327

2.  The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding?

Authors:  A J Bindels; R G Westendorp; M Frölich; J C Seidell; A Blokstra; A H Smelt
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  [Lipids profile in a group of hypothyroid patients vs. treated hypothyroid patients].

Authors:  Corina Găleşanu; Natalia Lisnic; Rodica Teslaru; Luminiţa Apostu; E Zbranca
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2004 Jul-Sep

5.  The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.

Authors:  R Serter; B Demirbas; B Korukluoglu; C Culha; E Cakal; Y Aral
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 6.  Thyroid disease and lipids.

Authors:  Leonidas H Duntas
Journal:  Thyroid       Date:  2002-04       Impact factor: 6.568

Review 7.  Cardiovascular and atherogenic aspects of subclinical hypothyroidism.

Authors:  G J Kahaly
Journal:  Thyroid       Date:  2000-08       Impact factor: 6.568

8.  A new strategy for thyroid function testing.

Authors:  G Caldwell; H A Kellett; S M Gow; G J Beckett; V M Sweeting; J Seth; A D Toft
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

9.  Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.

Authors:  S Miura; M Iitaka; H Yoshimura; S Kitahama; N Fukasawa; Y Kawakami; S Sakurai; M Urabe; Y Sakatsume; K Ito
Journal:  Intern Med       Date:  1994-07       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.